Sundrug Co.,Ltd. (TYO:9989)

Sundrug Statistics

Total Valuation

Sundrug has a market cap or net worth of JPY 493.49 billion. The enterprise value is 474.72 billion.

Market Cap	493.49B
Enterprise Value	474.72B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Sundrug has 116.97 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	116.97M
Shares Outstanding	116.97M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	4.61%
Owned by Institutions (%)	28.00%
Float	67.03M

Valuation Ratios

The trailing PE ratio is 15.71 and the forward PE ratio is 14.83. Sundrug's PEG ratio is 2.52.

PE Ratio	15.71
Forward PE	14.83
PS Ratio	0.61
PB Ratio	1.83
P/TBV Ratio	1.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.52

Enterprise Valuation

EV / Earnings	15.12
EV / Sales	0.58
EV / EBITDA	7.61
EV / EBIT	10.66
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.16.

Current Ratio	1.76
Quick Ratio	0.75
Debt / Equity	0.16
Debt / EBITDA	0.69
Debt / FCF	n/a
Interest Coverage	204.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	14.31%
Revenue Per Employee	114.06M
Profits Per Employee	4.40M
Employee Count	7,145
Asset Turnover	1.90
Inventory Turnover	6.18

Taxes

In the past 12 months, Sundrug has paid 13.68 billion in taxes.

Income Tax	13.68B
Effective Tax Rate	30.34%

Stock Price Statistics

The stock price has increased by +9.07% in the last 52 weeks. The beta is 0.20, so Sundrug's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+9.07%
50-Day Moving Average	4,471.92
200-Day Moving Average	4,405.33
Relative Strength Index (RSI)	42.06
Average Volume (20 Days)	254,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sundrug had revenue of JPY 814.94 billion and earned 31.40 billion in profits. Earnings per share was 268.49.

Revenue	814.94B
Gross Profit	208.27B
Operating Income	45.86B
Pretax Income	45.08B
Net Income	31.40B
EBITDA	63.68B
EBIT	45.86B
Earnings Per Share (EPS)	268.49

Balance Sheet

The company has 62.98 billion in cash and 44.22 billion in debt, giving a net cash position of 18.77 billion or 160.43 per share.

Cash & Cash Equivalents	62.98B
Total Debt	44.22B
Net Cash	18.77B
Net Cash Per Share	160.43
Equity (Book Value)	270.06B
Book Value Per Share	2,308.88
Working Capital	93.11B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 25.56%, with operating and profit margins of 5.63% and 3.85%.

Gross Margin	25.56%
Operating Margin	5.63%
Pretax Margin	5.53%
Profit Margin	3.85%
EBITDA Margin	7.81%
EBIT Margin	5.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 131.00, which amounts to a dividend yield of 3.11%.

Dividend Per Share	131.00
Dividend Yield	3.11%
Dividend Growth (YoY)	6.56%
Years of Dividend Growth	6
Payout Ratio	48.42%
Buyback Yield	-0.01%
Shareholder Yield	3.08%
Earnings Yield	6.36%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2017
Split Type	Forward
Split Ratio	2

Scores

Sundrug has an Altman Z-Score of 4.97 and a Piotroski F-Score of 3.

Altman Z-Score	4.97
Piotroski F-Score	3